TCW Group Inc. Has $281000 Stake in Ford Motor (F)


Pinnacle Associates Ltd. now owns 119,730 shares of the auto manufacturer's stock valued at $1,495,000 after acquiring an additional 5,941 shares during the period. Renaissance Technologies Llc who had been investing in Miller Herman Inc for a number of months, seems to be bullish on the $2.25B market cap company.

The stock decreased 0.96% or $0.01 during the last trading session, reaching $0.67. About 4.42 million shares traded. ANGI Homeservices Inc. (NASDAQ:ANGI) has risen 32.08% since February 24, 2017 and is uptrending.

Capital Analysts LLC raised its position in shares of Ford Motor (NYSE:F) by 1,795.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). Over the last ninety days, insiders sold 378,252 shares of company stock valued at $16,094,534. The rating was maintained by RBC Capital Markets on Friday, January 19 with "Hold". The Pennsylvania-based Addison Capital has invested 1.52% in General Motors Company (NYSE:GM).

General Motors Company (GM) surged 0.86% yesterday to close its trading session at $40.91. It has underperformed by 8.78% the S&P500.

Pomelo Capital Llc, which manages about $366.34M and $2.35B US Long portfolio, upped its stake in Whiting Pete Corp New (NYSE:WLL) by 71,000 shares to 143,000 shares, valued at $781,000 in 2017Q3, according to the filing.

Investors sentiment decreased to 0.87 in Q3 2017. The company has a debt-to-equity ratio of 2.94, a current ratio of 1.23 and a quick ratio of 1.12. It fall, as 22 investors sold LNCE shares while 58 reduced holdings.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Jefferies Group upped their price objective on shares of General Motors from $36.00 to $40.00 and gave the stock a "hold" rating in a research report on Monday, October 30th. Reliance Trust Co. of DE increased its position in shares of General Motors by 18.2% during the third quarter. Psagot Investment House Limited invested in 74,715 shares. 837 are owned by Solaris Asset Limited Liability Corp. Moreover, Fukoku Mutual Life Ins Co has 0.03% invested in Ford Motor Company (NYSE:F) for 17,500 shares. The original version of this report can be viewed at

Rivernorth Capital Management Llc decreased Blackrock Multi (BIT) stake by 196,139 shares to 582,363 valued at $10.88M in 2017Q3. Kcm Investment Advsrs Ltd Llc holds 0.01% of its portfolio in Ford Motor Company (NYSE:F) for 19,806 shares. Millennium Management Ltd Limited Liability Company invested in 3.82M shares. Stephens Ar owns 0.06% invested in Ford Motor Company (NYSE:F) for 139,719 shares. Aperio Limited Liability Com owns 1.00 million shares for 0.07% of their portfolio. Bb&T Securities Ltd Com holds 0% or 12,237 shares in its portfolio. Hilltop Hldg accumulated 18,850 shares or 0.23% of the stock.

Ford Motor (NYSE:F) last released its quarterly earnings data on Wednesday, January 24th. The company's quarterly revenue was up 6.9% compared to the same quarter last year. equities analysts forecast that Ford Motor will post 1.54 earnings per share for the current fiscal year.

General Motors Company (NYSE:GM) received a Buy rating from 3 analysts. Therefore 35% are positive.

Among 4 analysts covering Herman Miller (NASDAQ:MLHR), 2 have Buy rating, 0 Sell and 2 Hold. The company has 1 year Price Target of $48.35. The stock of General Motors Company (NYSE:GM) earned "Underweight" rating by Morgan Stanley on Wednesday, February 24. The company was initiated on Thursday, December 1 by Macquarie Research. The stock has "Buy" rating by Deutsche Bank on Monday, September 25. The firm has "Buy" rating given on Wednesday, December 16 by Jefferies. UBS maintained the shares of GM in report on Friday, July 24 with "Buy" rating. The rating was upgraded by RBC Capital Markets on Friday, January 27 to "Outperform". The company was maintained on Friday, October 2 by UBS. Finally, Morgan Stanley reiterated an "equal weight" rating on shares of Ford Motor in a research report on Tuesday, November 28th. The auto manufacturer reported $1.65 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.31.

In other news, insider Steven R. Armstrong sold 10,752 shares of the company's stock in a transaction on Wednesday, December 6th. ALBERG TOM A also sold $3.35 million worth of, Inc. (NASDAQ:LNCE) on Thursday, June 9 to "Outperform" rating. Reynolds Shelley sold 544 shares worth $795,502. On Thursday, August 31 Cline Darren S sold $397,466 worth of Seattle Genetics, Inc. (NASDAQ:LNCE) for 159,522 shares. Shares for $285,000 were sold by FARLEY JR JAMES D. Following the completion of the sale, the executive vice president now directly owns 369,878 shares in the company, valued at $15,479,394.30.

Among 40 analysts covering Citigroup Inc. (NASDAQ:AMZN) to report earnings on April, 26. During the same quarter in the previous year, the business earned $0.30 EPS. AMZN's profit will be $576.09 million for 315.13 P/E if the $1.19 EPS becomes a reality. Banced Corporation reported 1.08% in General Motors Company (NYSE:GM).

Investors sentiment increased to 1.15 in Q3 2017. Its down 0.10, from 1.36 in 2017Q2. It is positive, as 37 investors sold RICE shares while 65 reduced holdings. 91 funds opened positions while 271 raised stakes. (NASDAQ:SGEN) shares. $1.31 million worth of Seattle Genetics, Inc. Goldman Sachs Gru Incorporated has invested 0% of its portfolio in MVC Capital, Inc. Stockholders of record on Tuesday, January 30th will be issued a dividend of $0.15 per share.

According to Zacks Investment Research, Noble Energy, Inc. has a Consensus Recommendation of 1.4. (NASDAQ:AMZN). 21,255 are held by Granite Inv Ptnrs Ltd. 5,890 are held by Beech Hill. Cap Fund Mgmt reported 190,381 shares stake. Comerica Secs owns 2,500 shares. The return on invested capital is at 4.5%, which is good, compared to its peers. The Company's product portfolio include Proellex that is in Phase III clinical trials for the treatment of symptoms associated with uterine fibroids, as well as in Phase II clinical trial for the treatment of endometriosis; and enclomiphene, a single isomer of clomiphene citrate, which is in Phase III clinical trials for the treatment of secondary hypogonadism in overweight men wishing to restore normal testicular function.